Grant: Master's Award: Canada Graduate Scholarships
University of Toronto
$17,500.00
Investigating the role of platelet Jak2-mediated inflammatory response in atherosclerosis
EF 2023-24
Résumé
Cardiovascular disease (CVD) is the leading cause of death globally. Atherosclerosis, which involves a buildup of fatty deposits called plaques in artery walls, is the major cause of CVD. Inflammation drives atherosclerosis, involving various inflammatory cells and production of mediators. An intracellular molecule called Janus kinase 2 (Jak2) mediates this process as part of a signaling pathway downstream of diverse hormones and signaling molecules. And the effects of Jak2 depend on the cell and the context of activation. Platelets are the most well-known for hemostasis, but they also promote inflammation in atherosclerosis. The role of Jak2 in platelets in atherosclerosis is unclear, which warrants investigation into the mechanism behind how it impacts the inflammatory response. A genetic mouse model with Jak2 knocked out only in platelets (KO) will be created and compared with unmodified wildtype controls (WT). After 10 weeks of high cholesterol diet, atherosclerosis in the aorta will be compared between KO and WT by quantifying the plaque area using Oil-Red-O and hematoxylin and eosin staining. Plaque characteristics such as macrophage and platelet content will be studied using immunohistochemistry. The role of platelet Jak2 on the activation and inflammatory response of platelets and macrophages will be studied using flow cytometry and culture of macrophages derived from the bone marrow. Drugs that inhibit Jak2 are often used to treat myeloproliferative and autoimmune diseases. Studying the role of Jak2 inhibition will help guide the treatment of individuals that take these drugs to minimize the risk of CVD. The study of the novel role of platelet Jak2 may also lead to valuable novel therapeutic approaches against CVD.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
506154
Name
Kim Daeun
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Investigating the role of platelet Jak2-mediated inflammatory response in atherosclerosis
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Aorta; Atherosclerosis; Cardiovascular Disease; Cytokines; Inflammation; Insulin Resistance; Macrophages; Murine Model; Plaque; Platelets
Abstract
Cardiovascular disease (CVD) is the leading cause of death globally. Atherosclerosis, which involves a buildup of fatty deposits called plaques in artery walls, is the major cause of CVD. Inflammation drives atherosclerosis, involving various inflammatory cells and production of mediators. An intracellular molecule called Janus kinase 2 (Jak2) mediates this process as part of a signaling pathway downstream of diverse hormones and signaling molecules. And the effects of Jak2 depend on the cell and the context of activation. Platelets are the most well-known for hemostasis, but they also promote inflammation in atherosclerosis. The role of Jak2 in platelets in atherosclerosis is unclear, which warrants investigation into the mechanism behind how it impacts the inflammatory response. A genetic mouse model with Jak2 knocked out only in platelets (KO) will be created and compared with unmodified wildtype controls (WT). After 10 weeks of high cholesterol diet, atherosclerosis in the aorta will be compared between KO and WT by quantifying the plaque area using Oil-Red-O and hematoxylin and eosin staining. Plaque characteristics such as macrophage and platelet content will be studied using immunohistochemistry. The role of platelet Jak2 on the activation and inflammatory response of platelets and macrophages will be studied using flow cytometry and culture of macrophages derived from the bone marrow. Drugs that inhibit Jak2 are often used to treat myeloproliferative and autoimmune diseases. Studying the role of Jak2 inhibition will help guide the treatment of individuals that take these drugs to minimize the risk of CVD. The study of the novel role of platelet Jak2 may also lead to valuable novel therapeutic approaches against CVD.
Competitiondate
202312
Approvedterm2
1 yr 0 mth
Pinamesdelim
Kim, Daeun
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~